Latest Products
The implementation of unique device identification for medical devices will cause a major reshuffle in the industry, benefiting leading companies.
Release time:
2025-03-12 09:43
Recently, the pilot program for China's medical device unique identification system has officially launched, marking a significant step forward for China's medical device regulatory system towards becoming more scientific, legalized, internationalized, and modernized.
Medical Device Unique Identification (UDI) is the"identity card"of medical devices,"an international language". Establishing a unique identification system and strengthening the source coding will help to achieve full-chain traceability and understanding of medical devices through unique identification, strengthening the management of medical devices throughout their life cycle. As an internationally accepted practice, many countries and regions around the world are actively promoting the construction of a medical device unique identification system.
In the secondary market, Mindray Medical's total market capitalization surpassed that of the second-placed Winsway, securing its position as the"top company on the ChiNext board". Mindray Medical's rise to the top of the ChiNext market capitalization ranking is not only due to its impressive achievements, but also significantly aided by the boost from north-bound funds. Since5Month31Day, north-bound funds have continuously17trading days increased their holdings in Mindray Medical. North-bound funds' holdings of Mindray Medical increased from less than749ten thousand shares to over1166ten thousand shares, with an increase of1percent in less than56months.
The Chinese medical device market has a huge demand for product popularization and significant room for growth, and will maintain rapid expansion for a long time to come. The tiered diagnosis and treatment policy has expanded the primary market, significantly increasing medical needs; at the same time, encouraging the procurement of domestic equipment and accelerating the process of import substitution; policies encouraging innovation and R&D, priority reviews and other policies encourage enterprises to increase innovation and R&D. Domestic medical devices have a clear Price advantage over imported products, and the Brand and product quality of domestic leading enterprises are more guaranteed, giving them an advantage in domestic competition. In addition,2018year's annual report and2019year's first quarter report show that the domestic medical device sector continues to maintain healthy and steady growth, and we remain optimistic about the industry's long-term growth prospects. We can focus on Mindray Medical and Lepu Medical.
Industry giants, medical devices, healthcare, identification, unique, Beijing-Shanghai, funding, policies, domestic, China